Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Building a Human Stem Cell-Derived Branching Biliary Network to Study and Treat Hepatobiliary Diseases
FY 2022-23
Summary
The tree-branch like network of bile ducts is important to increase bile transport surface area at the human liver. In cholestatic liver diseases, bile flow blockage leads to toxin accumulation and damage to cholangiocytes, the cell type forming bile ducts. Liver transplant is the only effective solution for severe cholestatic disease but is limited by donor organ shortage. Human pluripotent stem cells (hPSCs) represent a cellular alternative to liver transplant as they can be differentiated into the required cell types at injury sites. Differentiating hPSCs into cholangiocytes capable of forming highly branched networks would enable us to study cholestatic diseases and possibly repair patient ductal injury by integration into the local biliary network. The Ogawa Lab has established a hPSC-derived cholangiocyte (hPSC-chol) platform to generate three-dimensional (3D) cholangiocyte organoids; however, abundant branching is still a challenge for us. We theorize that bile acids (BAs), which are required for ductal development and have reported positive effects on liver cell function and proliferation, may further mature cholangiocytes to produce branched networks. We will introduce BAs to 3D hPSC-chol cultures to observe any changes in organoid appearance that resemble ductal networks. These changes will be analyzed using imaging software and artificial intelligence to monitor cellular maturity. We will also assess hPSC-chol function by gene expression, protein markers and fluid secretion assays. We will assess whether transplanting BA-treated hPSC-chol into ductal-injury mice can reduce biliary damage. This hPSC-derived biliary network will help us model cholestatic disease progress and provide mature cholangiocytes to liver-transplant patients for cellular therapy.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486222
Name
Tian Britney
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Building a Human Stem Cell-Derived Branching Biliary Network to Study and Treat Hepatobiliary Diseases
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bile; Bile Acids; Bile Ducts; Biliary Networks; Cellular Therapy; Cholestasis; Injury; Liver; Stem Cells; Transplantation
Abstract
The tree-branch like network of bile ducts is important to increase bile transport surface area at the human liver. In cholestatic liver diseases, bile flow blockage leads to toxin accumulation and damage to cholangiocytes, the cell type forming bile ducts. Liver transplant is the only effective solution for severe cholestatic disease but is limited by donor organ shortage. Human pluripotent stem cells (hPSCs) represent a cellular alternative to liver transplant as they can be differentiated into the required cell types at injury sites. Differentiating hPSCs into cholangiocytes capable of forming highly branched networks would enable us to study cholestatic diseases and possibly repair patient ductal injury by integration into the local biliary network. The Ogawa Lab has established a hPSC-derived cholangiocyte (hPSC-chol) platform to generate three-dimensional (3D) cholangiocyte organoids; however, abundant branching is still a challenge for us. We theorize that bile acids (BAs), which are required for ductal development and have reported positive effects on liver cell function and proliferation, may further mature cholangiocytes to produce branched networks. We will introduce BAs to 3D hPSC-chol cultures to observe any changes in organoid appearance that resemble ductal networks. These changes will be analyzed using imaging software and artificial intelligence to monitor cellular maturity. We will also assess hPSC-chol function by gene expression, protein markers and fluid secretion assays. We will assess whether transplanting BA-treated hPSC-chol into ductal-injury mice can reduce biliary damage. This hPSC-derived biliary network will help us model cholestatic disease progress and provide mature cholangiocytes to liver-transplant patients for cellular therapy.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tian, Britney
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~